Browsing Tag
Vesper Bio
1 post
Vesper Bio reports 95% CSF progranulin boost in FTD-GRN trial—what’s next for VES001?
Vesper Bio’s oral FTD therapy VES001 boosts CSF progranulin by 95%. Explore what this means for dementia prevention and future clinical milestones.